{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:26:29Z","timestamp":1793622389279,"version":"4.5.0"},"reference-count":123,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,11,2]]},"DOI":"10.1080\/17474086.2026.2732994","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:47:18Z","timestamp":1789354038000},"page":"1255-1270","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Resistance mechanisms and therapeutic strategies after menin inhibitor failure in acute myeloid leukemia"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5264-8990","authenticated-orcid":false,"given":"Abdulrahman","family":"Alhajahjeh","sequence":"first","affiliation":[{"name":"Yale School of Medicine and Yale Comprehensive Cancer Center","place":["New Haven, USA"]},{"name":"King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Stahl","sequence":"additional","affiliation":[{"name":"Yale School of Medicine and Yale Comprehensive Cancer Center","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Zeidan","sequence":"additional","affiliation":[{"name":"Yale School of Medicine and Yale Comprehensive Cancer Center","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3352-0902","authenticated-orcid":false,"given":"Jan Philipp","family":"Bewersdorf","sequence":"additional","affiliation":[{"name":"Yale School of Medicine and Yale Comprehensive Cancer Center","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516192"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31041-9"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022481"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05812-3"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.11.001"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00826"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-01694"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00386-3"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114901"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-026-02959-6"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010219"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-1517"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05755-9"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024011"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025018178"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02501-6"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1011308"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70326"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2023.09.006"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00786-y"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2253"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04980"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1103154108"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0253-3"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.13.3714"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.01.026"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041974"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.2240"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0273"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.30"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-012252"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2021.1924600"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280801"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35332"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18040637"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.144"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223743"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.773"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2005.1.137"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2025000755"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.04.015"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.03.001"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.08.005"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.121"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/leusup.2014.5"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-4-13"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-442004"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1566"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30739"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-113597"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.09.025"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104783"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129126"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00914"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-766"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198218"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194384"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194827"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198959"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204375"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107777"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022480"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025031201"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208887"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000838"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-39"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281927"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00603-3"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2864-x"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19119-8"},{"key":"e_1_3_4_75_1","unstructured":"Phase 1 study to determine the safety and tolerability of ziftomenib combinations for the treatment of KMT2A-rearranged or NPM1-mutant relapsed\/refractory acute myeloid leukemia [internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06001788"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199170"},{"key":"e_1_3_4_77_1","unstructured":"Phase 1 dose escalation and expansion of ziftomenib in combination with quizartinib in acute myeloid leukemia [internet]. 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06769490"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094005"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016208"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2025.105268"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25953"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-665547"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023644"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000967412.62331.23"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.072443"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026297"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-24-0212"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1459"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-1001-z"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2025.06.003"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01610-0"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-015-0255-4"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000896"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280800"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.5150"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-158311"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm909"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511527"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-3191"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-23-0382"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31240-1"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116020"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025760"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.2662"},{"issue":"3","key":"e_1_3_4_105_1","first-page":"38","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"Pelcovits A","year":"2020","unstructured":"Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J (2013). 2020;103(3):38\u201340.","journal-title":"R I Med J (2013)"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-514778"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024870"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-47"},{"key":"e_1_3_4_109_1","unstructured":"A Phase 1 trial of the menin inhibitor SNDX-5613 (revumenib) (NSC# 852942) for maintenance therapy after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia acute myeloid leukemia and mixed phenotype acute leukemia [internet]. 2026. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07498465"},{"key":"e_1_3_4_110_1","unstructured":"Phase 2 trial of menin inhibitor BN104 as post hematopoietic stem cell transplantation maintenance in patients with acute leukemia [internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07101497"},{"key":"e_1_3_4_111_1","unstructured":"Phase 1 study of venetoclax\/azacitidine or venetoclax in combination with ziftomenib or standard induction Cytarabine\/Daunorubicin (7+3) chemotherapy in combination with ziftomenib for the treatment of patients with acute myeloid leukemia [internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05735184"},{"key":"e_1_3_4_112_1","unstructured":"A Phase 1\/2 first-in-human study of the menin-KMT2A (MLL1) inhibitor Bleximenib in participants with acute leukemia (cAmelot-1) [internet]. 2021. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04811560"},{"key":"e_1_3_4_113_1","unstructured":"A Phase 1b study of Bleximenib in combination with AML-Directed therapies for participants with acute myeloid leukemia harboring KMT2A or NPM1 alterations [internet]. 2022. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05453903"},{"key":"e_1_3_4_114_1","unstructured":"A Phase 3 randomized Double-blind placebo-controlled study of Bleximenib venetoclax and Azacitidine for the treatment of participants with newly diagnosed acute myeloid leukemia harboring KMT2A rearrangements or NPM1 mutations who are ineligible for intensive chemotherapy [internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06852222"},{"key":"e_1_3_4_115_1","unstructured":"Bleximenib or placebo in combination with standard induction and consolidation therapy followed by maintenance for the treatment of patients with newly diagnosed KMT2A-rearranged or NPM1-mutant acute myeloid leukemia eligible for intensive chemotherapy: a Double-blind Phase 3 study [internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07223814"},{"key":"e_1_3_4_116_1","unstructured":"A multi-site break through Cancer trial: phase ii study investigating dual inhibition of BCL2 and Menin in AML MRD using the combination of venetoclax and revumenib [internet]. 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06284486"},{"key":"e_1_3_4_117_1","unstructured":"A Phase I trial of revumenib in combination with 7+3 (7 days of cytarabine and 3 days of Daunorubicin) + midostaurin induction chemotherapy for the frontline treatment of NPM1 and FLT3 mutated AML [internet]. 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06313437"},{"key":"e_1_3_4_118_1","unstructured":"A Phase 3 randomized Double-blind placebo-controlled study of revumenib in combination with intensive chemotherapy in participants with newly diagnosed AML with an NPM1 mutation [internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07211958"},{"key":"e_1_3_4_119_1","unstructured":"A Phase I\/II multicenter open label clinical study evaluating the safety pharmacokinetics and efficacy of the combination of the menin inhibitor BN104 for the treatment of patients with acute myeloid leukemia [internet]. 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06746519"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4389"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006575"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005037"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011917"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-1649"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)01623-4"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2732994","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17474086.2026.2732994","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2732994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:34:34Z","timestamp":1793619274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2026.2732994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":123,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,2]]}},"alternative-id":["10.1080\/17474086.2026.2732994"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2026.2732994","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}